Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

37 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Plasticity of melanoma and EMT-TF reprogramming.
Tulchinsky E, Pringle JH, Caramel J, Ansieau S. Tulchinsky E, et al. Among authors: caramel j. Oncotarget. 2014 Jan 15;5(1):1-2. doi: 10.18632/oncotarget.1662. Oncotarget. 2014. PMID: 24369126 Free PMC article. No abstract available.
A stemness-related ZEB1-MSRB3 axis governs cellular pliancy and breast cancer genome stability.
Morel AP, Ginestier C, Pommier RM, Cabaud O, Ruiz E, Wicinski J, Devouassoux-Shisheboran M, Combaret V, Finetti P, Chassot C, Pinatel C, Fauvet F, Saintigny P, Thomas E, Moyret-Lalle C, Lachuer J, Despras E, Jauffret JL, Bertucci F, Guitton J, Wierinckx A, Wang Q, Radosevic-Robin N, Penault-Llorca F, Cox DG, Hollande F, Ansieau S, Caramel J, Birnbaum D, Vigneron AM, Tissier A, Charafe-Jauffret E, Puisieux A. Morel AP, et al. Among authors: caramel j. Nat Med. 2017 May;23(5):568-578. doi: 10.1038/nm.4323. Epub 2017 Apr 10. Nat Med. 2017. PMID: 28394329
ZEB1-mediated melanoma cell plasticity enhances resistance to MAPK inhibitors.
Richard G, Dalle S, Monet MA, Ligier M, Boespflug A, Pommier RM, de la Fouchardière A, Perier-Muzet M, Depaepe L, Barnault R, Tondeur G, Ansieau S, Thomas E, Bertolotto C, Ballotti R, Mourah S, Battistella M, Lebbé C, Thomas L, Puisieux A, Caramel J. Richard G, et al. Among authors: caramel j. EMBO Mol Med. 2016 Oct 4;8(10):1143-1161. doi: 10.15252/emmm.201505971. Print 2016 Oct. EMBO Mol Med. 2016. PMID: 27596438 Free PMC article.
Oncogenic roles of EMT-inducing transcription factors.
Puisieux A, Brabletz T, Caramel J. Puisieux A, et al. Among authors: caramel j. Nat Cell Biol. 2014 Jun;16(6):488-94. doi: 10.1038/ncb2976. Nat Cell Biol. 2014. PMID: 24875735 Review.
A targeted genomic alteration analysis predicts survival of melanoma patients under BRAF inhibitors.
Louveau B, Delyon J, De Moura CR, Battistella M, Jouenne F, Golmard L, Sadoux A, Podgorniak MP, Chami I, Marco O, Caramel J, Dalle S, Feugeas JP, Dumaz N, Lebbe C, Mourah S. Louveau B, et al. Among authors: caramel j. Oncotarget. 2019 Mar 1;10(18):1669-1687. doi: 10.18632/oncotarget.26707. eCollection 2019 Mar 1. Oncotarget. 2019. PMID: 30899440 Free PMC article.
ZEB1 transcription factor promotes immune escape in melanoma.
Plaschka M, Benboubker V, Grimont M, Berthet J, Tonon L, Lopez J, Le-Bouar M, Balme B, Tondeur G, de la Fouchardière A, Larue L, Puisieux A, Grinberg-Bleyer Y, Bendriss-Vermare N, Dubois B, Caux C, Dalle S, Caramel J. Plaschka M, et al. Among authors: caramel j. J Immunother Cancer. 2022 Mar;10(3):e003484. doi: 10.1136/jitc-2021-003484. J Immunother Cancer. 2022. PMID: 35288462 Free PMC article.
Pleiotropic Roles for ZEB1 in Cancer.
Caramel J, Ligier M, Puisieux A. Caramel J, et al. Cancer Res. 2018 Jan 1;78(1):30-35. doi: 10.1158/0008-5472.CAN-17-2476. Epub 2017 Dec 18. Cancer Res. 2018. PMID: 29254997 Review.
37 results